103 results
8-K
EX-10.1
HRTX
Heron Therapeutics Inc
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
” or “material weaknesses” (each as defined by the Public Company Accounting Oversight Board) in its internal control over financial reporting, or any fraud
8-K
EX-10.1
j50og7rm kr
10 Aug 22
Entry into a Material Definitive Agreement
4:46pm